AVITA Medical Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $74.9M+17.2% YoYTTM through 30 Jun 2026
Net Income -$43.1MTTM through 30 Jun 2026
Free Cash Flow -$24.6MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 82.1% |
| EBITDA Margin | -43.7% |
| Operating Margin | -59.4% |
| Net Margin | -57.5% |
Returns
154.8%ROE
-90.2%ROA
Balance Sheet Health
Debt / Equity-1.86x
Current Ratio0.41x
Net Debt$37.5M
Cash & Equivalents$9.1M
Quality Metrics
Altman Z-Score-11.56
Piotroski F-Score3 / 9
FCF Margin-32.9%
Rule of 4025.0
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $71.6M
Diluted EPS-$1.44TTMFY2025: $-1.74
Dividend
No dividend
Capital Allocation
R&D Spend$20.1M
Capex Intensity0.5%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.